Skip to content
Wednesday, March 29, 2023
Latest:
  • Baylor surgeons aim to improve colorectal cancer care through research
  • Uncovering drivers of glioma-related epilepsy
  • Debating Diets: What is the pescatarian diet?
  • Researchers pave the way for solutions to problems affecting preterm infants
  • Growing Up Baylor – DeBakey High School Edition: Dr. Lynda Chima Aririguzo

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

Search Results for: prostate cancer

A microscopic view of prostate cancer. It appears as a field of hazy pink and white with splotches of purple indicating cancer cells.
From The Labs 

A novel strategy to suppress prostate cancer growth

October 26, 2022November 3, 2022androgen receptor, castration therapy, COP1, Gata2, Prostate Cancer, Research, treatment resistance

The researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.

Read more
From The Labs 

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

Read more
From The Labs 

New oncogene MNX1 contributes to higher incidence of prostate cancer among African American men

October 12, 2016African American men, AKT, lipid metabolism, oncogene MNX1, Prostate Cancer, testosterone

Genetic factors can explain, at last in part, the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.

Read more
blue-cure-lights-featured
Momentum 

Prostate cancer: What you need to know

September 14, 2016September 9, 2019Allison Mickey, Blue Cure Foundation, Cancer, Community, Dr. Jennifer Taylor, Events, Healthcare, Houston, Men's Health, Prostate Cancer, Urology

During the month of September, Baylor College of Medicine will be partnering with the Blue Cure Foundation for its annual prostate cancer awareness campaign, Light

Read more
From The Labs 

Altered metabolism in castration-resistant prostate cancer may point to new therapies

September 13, 2016June 23, 2020altered metabolism, Cancer, castration-resistant, hexosamine biosynthetic pathway, metabolism, Prostate Cancer, therapeutic target

Advanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the

Read more
From The Labs 

Mouse model shows that Notch activation can drive metastatic prostate cancer

August 23, 2016May 4, 2018Metastasis, metastatic prostate cancer, mouse model, Notch signaling pathway, Prostate Cancer, Pten gene, Research

Nearly 200 thousand men are diagnosed with prostate cancer every year. Most of the deaths associated with prostate cancer occur in advanced stages of the

Read more
Momentum 

Baylor College of Medicine lights up blue in honor of Prostate Cancer Awareness Month

September 4, 2015October 7, 2016Blue Cure Foundation, Cancer, Community, Dan L. Duncan Cancer Center, Events, Glenna Vickers, Healthcare, Houston, Light it up blue, Men's Health, Prostate Cancer

September officially kicks off National Prostate Cancer Awareness Month, and in a show of support for increased awareness, education, research and clinical advances, the Baylor

Read more
From The Labs 

Coactivator forges pathway for survival of metastatic prostate cancer

March 16, 2015

By Ruth SoRelle, M.P.H. A steroid receptor coactivator (SRC-2) drives the metabolic mechanism that allows prostate cancer not only to grow but also to spread

Read more
From The Labs 

Blocking a coactivator may be answer to androgen-resistant prostate cancer

November 4, 2014

By Ruth SoRelle, M.P.H. Treating advanced prostate cancer with drugs that block androgens or male hormones can result in resistance to the drugs, and is

Read more
A bariatric surgeon uses a diagram of the human body to consult with a patient about the benefits of bariatric surgery.
Momentum 

New research supports benefits of bariatric surgery in long-term weight loss and cancer risk reduction

July 27, 2022July 26, 2022Bariatric surgery, Cancer, Michael E. DeBakey Department of Surgery

Collaboration between bariatric surgery and and oncology teams identify patients with obesity who may be at a cancer risk.

Read more
  • ← Previous

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: a transparent heart

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951